Plaintiff Wins $28M Verdict in PA Xarelto Lawsuit Trial
More Info: Defective Drugs
A Pennsylvania jury awarded an Indiana woman a $28 million verdict in the state’s first Xarelto lawsuit trial. The plaintiff suffered gastrointestinal bleeding about a year after being prescribed the blood-thinning drug, according to a press release.
The verdict followed nearly a month of testimony in court of Common Pleas. The plaintiff’s attorneys accused Johnson & Johnson and Bayer of downplaying the potentially life-threatening side effects of the Xarelto drug.
It took the jury less than two days to come to a verdict, awarding the plaintiff and her husband $1.8 million in compensatory damages and $26 million in punitive damages.
Pharmaceutical giants Bayer and Johnson & Johnson have been named in more than 20,000 lawsuits related to the Xarelto drug. Approximately 2,000 of those lawsuits are part of the mass tort program in Philadelphia.
See the full, original post here: https://www.legalscoops.com/plaintiff-wins-28m-verdict-in-pa-xarelto-lawsuit-trial/
TriMark Legal Funding was founded in 2003 and is one of America's original lawsuit funding companies. TriMark provides pre-settlement loans and post-settlement loans to injured plaintiffs who are involved in personal injury lawsuits, employment litigation, work injury accidents and workers compensation settlement funding, mass tort litigation, and multidistrict litigation. We also provide loans for lawyers and law firm portfolio funding.
|Mass Torts||Other MDL|
Click here to see the original article.